Hypertriglyceridemia Is an Independent Risk Factor for Cardiovascular Diseases in Korean Adults Aged 30–49 Years: a Nationwide Population-Based Study
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Objective: This study was conducted to estimate the incidence of cardiovascular disease (CVD) independently from low-density lipoprotein (LDL) cholesterol according to triglyceride (TG) levels in young adults. Methods: Subjects aged 30–49 years with data from routine health check-ups provided by the National Health Insurance Service during 2009 were selected. The primary outcome was incident CVD, defined as a composite of ischemic heart disease and ischemic stroke during the follow-up period from 2009 to 2018. Results: The mean age of study subjects (n=1,823,537) was 40.1±5.7 years, and the median follow-up period was 8.3 years. The quartiles of serum TG levels at the baseline were calculated: Q1, <74 mg/dL; Q2, 74–108 mg/dL; Q3, 109–166 mg/dL; and Q4: >166 mg/dL. The highest quartile of TG levels (Q4) had a significantly higher risk of the primary outcome than Q1 (hazard ratio [HR], 2.40 [95% confidence interval; CI, 2.33–2.47]). Q2 and Q3 also experienced the primary outcome more frequently than Q1 (HR, 1.37 [95% CI, 1.33–1.42] and HR, 1.80 [95% CI, 1.75–1.86], respectively). Even after adjustment for age, sex, obesity, alcohol drinking amount, smoking, LDL cholesterol, diabetes mellitus, hypertension, lipid-lowering medication use, and family history of CVD, there was a significant dose-response relationship between TG quartiles and the risk of the primary outcome (HR per quartile, 1.13 [95% CI, 1.12–1.14]). Conclusion: In conclusion, in the Korean population aged 30–49 years, high TG levels independently increased future CVD risk in both men and women.
Abstract
Objective: This study was conducted to estimate the incidence of cardiovascular disease (CVD) independently from low-density lipoprotein (LDL) cholesterol according to triglyceride (TG) levels in young adults. Methods: Subjects aged 30–49 years with data from routine health check-ups provided by the National Health Insurance Service during 2009 were selected. The primary outcome was incident CVD, defined as a composite of ischemic heart disease and ischemic stroke during the follow-up period from 2009 to 2018. Results: The mean age of study subjects (n=1,823,537) was 40.1±5.7 years, and the median follow-up period was 8.3 years. The quartiles of serum TG levels at the baseline were calculated: Q1, <74 mg/dL; Q2, 74–108 mg/dL; Q3, 109–166 mg/dL; and Q4: >166 mg/dL. The highest quartile of TG levels (Q4) had a significantly higher risk of the primary outcome than Q1 (hazard ratio [HR], 2.40 [95% confidence interval; CI, 2.33–2.47]). Q2 and Q3 also experienced the primary outcome more frequently than Q1 (HR, 1.37 [95% CI, 1.33–1.42] and HR, 1.80 [95% CI, 1.75–1.86], respectively). Even after adjustment for age, sex, obesity, alcohol drinking amount, smoking, LDL cholesterol, diabetes mellitus, hypertension, lipid-lowering medication use, and family history of CVD, there was a significant dose-response relationship between TG quartiles and the risk of the primary outcome (HR per quartile, 1.13 [95% CI, 1.12–1.14]). Conclusion: In conclusion, in the Korean population aged 30–49 years, high TG levels independently increased future CVD risk in both men and women.
참고문헌 (34)
- Faergeman O, "Plasma triglycerides and cardiovascular events in the treating to new targets and incremental decrease in end-points through aggressive lipid lowering trials of statins in patients with coronary artery disease", Am J Cardiol, 104, pp.459~463 (2009)
- Criqui MH, "Plasma triglyceride level and mortality from coronary heart disease", N Engl J Med, 328, pp.1220~1225 (1993)
- Frick MH, "Helsinki Heart Study : primaryprevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease", N Engl J Med, 317, pp.1237~1245 (1987)
- Keech A, "Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus(the FIELD study) : randomised controlled trial", Lancet, 366, pp.1849~1861 (2005)
- ACCORD Study GroupGinsberg HN, "Effects of combination lipid therapy in type 2 diabetes mellitus", N Engl J Med, 362, pp.1563~1574 (2010)
- Moon JH, "Optimal high-density lipoprotein cholesterol cutoff for predicting cardiovascular disease : comparison of the Korean and US National Health and Nutrition Examination Surveys", J Clin Lipidol, 9, pp.334~342 (2015)
- Kim EH, "Serum triglyceride levels and cardiovascular disease events in Koreans", Cardiology, 131, pp.228~235 (2015)
- 임수, "Components of Metabolic Syndrome in Korean Adults: A Hospital-Based Cohort at Seoul National University Bundang Hospital", Journal of Obesity & Metabolic Syndrome, 28(2), pp.118~128 (2019), 대한비만학회[DOI]
- Heitmann BL, "The effects of gender and age on associations between blood lipid levels and obesity in Danish men and women aged 35–65 years", J Clin Epidemiol, 45, pp.693~702 (1992)
- Yoon JW, "Influence of the definition of"metabolically healthy obesity"on the progression of coronary artery calcification", PLoS One, 12, pp.e0178741~ (2017)
- Koo BK, "The incidence and prevalence of diabetes mellitus and related atherosclerotic complications in Korea : a National Health Insurance Database Study", PLoS One, 9, pp.e110650~ (2014)
- Kwon S, "Visit-to-visit variability of metabolic parameters and risk of heart failure : a nationwide population-based study", Int J Cardiol, 293, pp.153~158 (2019)
- Expert Panel on Detection, "Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)", JAMA, 285, pp.2486~2497 (2001)
- Eue-Keun Choi, "Cardiovascular Research Using the Korean National Health Information Database", Korean Circulation Journal, 50(9), pp.754~772 (2020), 대한심장학회[DOI]
- Nordestgaard BG, "Fasting is not routinely required for determination of a lipid profile : clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine", Eur Heart J, 37, pp.1944~1958 (2016)
- Wang X, "Sex differences in lipid and lipoprotein metabolism : it's not just about sex hormones", J Clin Endocrinol Metab, 96, pp.885~893 (2011)
- Bitzur R, "Triglycerides and HDL cholesterol : stars or second leads in diabetes", Diabetes Care, 32(Suppl 2), pp.S373~S377 (2009)
- Goldstein JL, "Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine beta-very low density lipoproteins", J Biol Chem, 255, pp.1839~1848 (1980)
- Reiner Ž, "Hypertriglyceridaemia and risk of coronary artery disease", Nat Rev Cardiol, 14, pp.401~411 (2017)
- Liu J, "Effects of blood triglycerides on cardiovascular and all-cause mortality : a systematic review and meta-analysis of 61 prospective studies", Lipids Health Dis, 12, pp.159~ (2013)
- Klempfner R, "Elevated triglyceride level is independently associated with increased all-cause mortality in patients with established coronary heart disease : twenty-two-year follow-up of the bezafibrate infarction prevention study and registry", Circ Cardiovasc Qual Outcomes, 9, pp.100~108 (2016)
- Zhu L, "Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia : a secondary analysis of the ACCORDION study", Cardiovasc Diabetol, 19, pp.28~ (2020)
- Xia TL, "The triglyceride paradox in the mortality of coronary artery disease", Lipids Health Dis, 18, pp.21~ (2019)
- Cheng YT, "Lower serum triglyceride level is a risk factor for in-hospital and late major adverse events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention-a cohort study", BMC Cardiovasc Disord, 14, pp.143~ (2014)
- Deng QW, "The short-term prognostic value of the triglycerideto-high-density lipoprotein cholesterol ratio in acute ischemic stroke", Aging Dis, 9, pp.498~506 (2018)
- Cheng KH, "Lipid paradox in acute myocardial infarction-the association with 30-day in-hospital mortality", Crit Care Med, 43, pp.1255~1264 (2015)
- Dziedzic T, "Lower serum triglyceride level is associated with increased stroke severity", Stroke, 35, pp.e151~e152 (2004)
- Lee SH, "Association between body mass index and mortality in the Korean elderly : a nationwide cohort study", PLoS One, 13, pp.e0207508~ (2018)
- Jee SH, "Body-mass index and mortality in Korean men and women", N Engl J Med, 355, pp.779~787 (2006)
- Kim H, "Prognostic effect of body mass index to mortality in Korean older persons", Geriatr Gerontol Int, 18, pp.538~546 (2018)
- Park J, "Validation of diagnostic codes of major clinical outcomes in a National Health Insurance database", Int J Arrhythm, 20, pp.1~7 (2019)
- Ono Y, "Validity of claims diagnosis codes for cardiovascular diseases in diabetes patients in Japanese Administrative Database", Clin Epidemiol, 12, pp.367~375 (2020)
- Jun Yup Kim, "Executive Summary of Stroke Statistics in Korea 2018: A Report from the Epidemiology Research Council of the Korean Stroke Society", 대한뇌졸중영문학회지, 21(1), pp.42~59 (2019), 대한뇌졸중학회[DOI]
- Pradhan AD, "Rationale and design of the pemafibrate to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes(PROMINENT)study", Am Heart J, 206, pp.80~93 (2018)